Skip to main content
Top

Rheumatology International

Issue 3/2024

Content (20 Articles)

Stroke Review

Post-stroke rehabilitation in the peri-pandemic COVID-19 era

Meirgul I. Assylbek, Burhan Fatih Kocyigit, Marlen Yessirkepov, Olena Zimba

Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis

Javier Courel-Ibáñez, Tomas Vetrovsky, Nora Růžičková, Concepción Marañón, Krzysztof Durkalec-Michalski, Michal Tomcik, Mária Filková

Open Access Mood Disorders Protocols

The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol

Natasha Cox, Ashley Hawarden, Ram Bajpai, Saeed Farooq, Helen Twohig, Sara Muller, Ian C. Scott

Scoliosis Clinical Trials

Exercise programs for scoliosis in juvenile idiopathic arthritis: a randomized-controlled study

Eylul Pinar Kisa, Ela Tarakcı, Gokce Leblebici, Arzu Razak Ozdincler, Ozgur Kasapcopur

Open Access Systemic Lupus Erythematosus Observational Research

Prevalence and outcomes of end-stage kidney disease in patients with systemic lupus erythematous: a population-based study

Chunhuan Lao, Philippa Van Dantzig, Douglas White, Kannaiyan Rabindranath, Donna Foxall, Ross Lawrenson

Ankylosing Spondylitis Observational Research

A lower frequency of inflammatory back pain in male patients with ankylosing spondylitis compared with female patients

Gökçe Kenar, Handan Yarkan-Tuğsal, Pınar Çetin-Özmen, Dilek Solmaz, Gerçek Can, Fatoş Önen

Spondyloarthropathy Observational Research

Predictors of treatment failure of non-steroidal anti-inflammatory drugs in patients with axial spondyloarthritis with focus on haptoglobin, haptoglobin polymorphism and zonulin

Magdalena Chmielińska, Marzena Olesińska, Anna Felis-Giemza, Agnieszka Paradowska-Gorycka, Karolina Palej, Julita Rejmer-Szcześniak, Dariusz Szukiewicz

Methotrexate Observational Research

Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use

Belkis Nihan Coskun, Burcu Yagiz, Gokhan Ocakoglu, Ediz Dalkilic, Yavuz Pehlivan

Open Access Telemedicine Patient Opinion

Prediction of the acceptance of telemedicine among rheumatic patients: a machine learning-powered secondary analysis of German survey data

Felix Muehlensiepen, Pascal Petit, Johannes Knitza, Martin Welcker, Nicolas Vuillerme

Psoriatic Arthritis Validation Studies

Validity and reliability of the Duruöz Hand Index in patients with psoriatic arthritis

Mehmet Tuncay Duruöz, Kemal Nas, Sevtap Acer Kasman, Nuran Öz, Emre Uzun, Halise Hande Gezer

Gout Case Based Review

Miliarial-type gout in association with chronic use of glucocorticoids

A. Enríquez-Luna, C. Soto-Fajardo, F. Carranza-Enríquez, D. Clavijo-Cornejo, A. Lopez-Reyes, C. Pineda

An overlapping case of IgG4-related disease and systemic lupus erythematosus treated with belimumab: a case-based review

Megumi Iwamoto, Hiromitsu Asashima, Toshiki Sugita, Fumina Kawashima, Naoki Sugita, Akiyoshi Rai, Yuki Kuroda, Akira Kawashima, Daiki Tabuchi, Satoshi Akao, Ryota Sato, Taihei Nishiyama, Hirofumi Toko, Fumika Honda, Ayako Ohyama, Ayako Kitada, Saori Abe, Haruka Miki, Shinya Hagiwara, Yuya Kondo, Hiroto Tsuboi, Isao Matsumoto

Osteoarthrosis Correspondence

Franz Liszt’s hand osteoarthritis

Ilke Coskun Benlidayi

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine